tiprankstipranks
Trending News
More News >
Regional Health Properties, Inc. (RHEP)
:RHEP
Advertisement

Regional Health Properties (RHEP) AI Stock Analysis

Compare
250 Followers

Top Page

RH

Regional Health Properties

(OTC:RHEP)

Rating:44Neutral
Price Target:
$2.50
▲(18.48%Upside)
The overall stock score for Regional Health Properties is low due to critical financial challenges and the looming risk of delisting. Valuation concerns and corporate events, particularly the delisting proceedings, are significant negatives. While technical indicators show some positive trends, they are not enough to overshadow the financial and corporate challenges.

Regional Health Properties (RHEP) vs. SPDR S&P 500 ETF (SPY)

Regional Health Properties Business Overview & Revenue Model

Company DescriptionRegional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The company's facilities provide a range of healthcare services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of December 31, 2021, it owned, leased, or managed 24 facilities primarily in the Southeastern United States of America. The company was incorporated in 1991 and is headquartered in Suwanee, Georgia.
How the Company Makes MoneyRegional Health Properties generates revenue primarily through leasing its portfolio of healthcare and senior living facilities to third-party operators. The company's business model involves acquiring properties and leasing them under long-term agreements, which provides a steady stream of rental income. These leases often include annual rent escalations, contributing to revenue growth. Additionally, RHEP may engage in property sales or acquisitions as part of its strategy to optimize its portfolio, which can also impact earnings. The company's financial performance is influenced by the operational success of its tenants, occupancy rates of the facilities, and overall demand in the healthcare real estate market.

Regional Health Properties Financial Statement Overview

Summary
Regional Health Properties faces significant financial challenges, with weak profitability and a highly leveraged balance sheet. Despite some revenue recovery, sustained improvement in margins and cash flow generation is crucial. The company must address high debt levels to stabilize its financial position.
Income Statement
42
Neutral
Regional Health Properties has shown volatile revenue trends with a notable decline in 2022. The TTM figures indicate some recovery with a revenue increase, but profitability remains weak with negative net income over multiple periods. Gross profit margin has improved slightly in the TTM, but EBIT and EBITDA margins are low, indicating operational challenges.
Balance Sheet
30
Negative
The company's financial position appears strained with a negative stockholders' equity and a high debt-to-equity ratio due to significant liabilities. Despite a reduction in total debt in the most recent period, the equity ratio is negative, reflecting a highly leveraged balance sheet and potential financial instability.
Cash Flow
50
Neutral
Cash flow from operations has been inconsistent, with free cash flow improving in the TTM period. However, the operating cash flow to net income ratio is not favorable due to negative net income. The company has managed to generate positive free cash flow, but the underlying cash flow stability needs improvement.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue21.51M18.34M17.16M35.92M26.69M17.58M
Gross Profit8.14M8.30M8.00M9.98M10.31M10.35M
EBITDA1.72M2.22M1.45M-1.93M4.08M5.07M
Net Income-3.52M-3.22M-3.89M-6.87M-1.18M-688.00K
Balance Sheet
Total Assets59.28M60.47M62.18M68.58M105.70M108.03M
Cash, Cash Equivalents and Short-Term Investments3.06M582.00K953.00K843.00K6.79M4.19M
Total Debt51.51M43.96M45.68M55.40M84.94M90.32M
Total Liabilities63.44M63.38M62.00M64.86M95.30M96.92M
Stockholders Equity-4.16M-2.92M185.00K3.72M10.40M11.10M
Cash Flow
Free Cash Flow1.04M1.41M2.75M-3.88M4.77M845.00K
Operating Cash Flow1.58M1.94M3.71M-3.60M4.89M1.29M
Investing Cash Flow-540.00K-530.00K-958.00K-281.00K-123.00K-450.00K
Financing Cash Flow-1.96M-2.13M-2.48M-2.06M-2.42M-1.39M

Regional Health Properties Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.11
Price Trends
50DMA
2.30
Negative
100DMA
1.98
Positive
200DMA
1.92
Positive
Market Momentum
MACD
0.01
Positive
RSI
44.60
Neutral
STOCH
44.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RHEP, the sentiment is Negative. The current price of 2.11 is below the 20-day moving average (MA) of 2.39, below the 50-day MA of 2.30, and above the 200-day MA of 1.92, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 44.60 is Neutral, neither overbought nor oversold. The STOCH value of 44.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RHEP.

Regional Health Properties Risk Analysis

Regional Health Properties disclosed 42 risk factors in its most recent earnings report. Regional Health Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Regional Health Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
NHNHC
75
Outperform
$1.60B14.9411.19%2.48%19.16%31.92%
68
Neutral
$873.79M31.9111.28%30.04%43.47%
55
Neutral
$482.20M-70.23%26.13%37.38%
BKBKD
51
Neutral
$1.86B-91.17%3.88%-34.30%
49
Neutral
$46.08M-951.52%-0.70%-2.38%
46
Neutral
C$201.03M-3.36-23.14%2.62%20.76%-0.69%
44
Neutral
$5.31M
23.70%-109.93%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RHEP
Regional Health Properties
2.37
0.19
8.72%
BKD
Brookdale Senior Living
7.80
0.07
0.91%
SNDA
Sonida Senior Living
25.05
-6.49
-20.58%
NHC
National Healthcare
97.39
-26.69
-21.51%
MODV
ModivCare
3.10
-22.36
-87.82%
PNTG
Pennant Group
24.46
-2.71
-9.97%

Regional Health Properties Corporate Events

M&A Transactions
Regional Health Properties Extends Merger Deadline to August
Neutral
Jun 23, 2025

On April 14, 2025, Regional Health Properties and SunLink Health Systems entered into a merger agreement, with Regional set to be the surviving corporation. Due to outstanding shareholder approvals, the termination date for the merger was extended from June 30, 2025, to August 11, 2025, allowing more time for the necessary approvals to be obtained.

Delistings and Listing ChangesM&A Transactions
Regional Health Properties Faces NYSE Delisting Decision
Negative
Jun 13, 2025

Regional Health Properties, Inc. has faced a decision by the NYSE American LLC to delist its common stock and Series A Preferred Shares due to non-compliance with listing standards, with the delisting process initiated on June 11, 2025. Despite this setback, Regional remains committed to a proposed merger with SunLink Health Systems, Inc., although there is no guarantee that any securities issued in the merger will be approved by a national securities exchange.

Delistings and Listing ChangesM&A Transactions
Regional Health Faces NYSE Delisting Proceedings
Negative
May 19, 2025

Regional Health Properties, Inc. is facing delisting proceedings from the NYSE American due to non-compliance with listing standards, as affirmed by the exchange’s Committee for Review. Despite this challenge, the company remains committed to its planned merger with SunLink Health Systems, although the approval of any securities issued in the merger by a national securities exchange is not guaranteed.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 15, 2025